Wednesday
Aug252010
NCT01189383
IL15 Dendritic Cell Vaccine for Patients With Resected Stage IIIc and Stage IV Melanoma
Conditions: Stage IIIc/IV Melanoma
Sponsors: Baylor Research Institute
Phase I, II
Date:
August 25, 2010

Categories
Cancer - Melanoma
